| scholarly article | Q13442814 |
| P2093 | author name string | O'Brien RM | |
| Barr FG | |||
| Durham SK | |||
| Goldman JK | |||
| Powell DR | |||
| Svitek CA | |||
| Ayala JE | |||
| Streeper RS | |||
| Suwanichkul A | |||
| Desgrosellier JS | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | preproinsulin | Q7240673 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 1885-1889 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: transcription factor FKHR binds the insulin response sequence | |
| P478 | volume | 48 |
| Q24648525 | A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange |
| Q40714220 | A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. |
| Q34511038 | AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity |
| Q33964561 | An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene |
| Q28214761 | An mRNA splice variant of the AFX gene with altered transcriptional activity |
| Q24533515 | Antagonistic effects of phorbol esters on insulin regulation of insulin-like growth factor-binding protein-1 (IGFBP-1) but not glucose-6-phosphatase gene expression |
| Q40572878 | Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. |
| Q34049345 | CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis |
| Q34268205 | Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity |
| Q39896136 | Control of cell number by Drosophila FOXO: downstream and feedback regulation of the insulin receptor pathway |
| Q44062730 | Cystathionine beta-synthase is coordinately regulated with proliferation through a redox-sensitive mechanism in cultured human cells and Saccharomyces cerevisiae |
| Q40680092 | DYRK1 is a co-activator of FKHR (FOXO1a)-dependent glucose-6-phosphatase gene expression. |
| Q34310784 | Decrease in Mitochondrial Function in Rat Cardiac Permeabilized Fibers Correlates With the Aging Phenotype |
| Q90918133 | Different roles of insulin receptor a and b in maintaining blood glucose homeostasis in zebrafish |
| Q40886678 | Differential role of hepatocyte nuclear factor-1 in the regulation of glucose-6-phosphatase catalytic subunit gene transcription by cAMP in liver- and kidney-derived cell lines |
| Q24534371 | Down-regulation of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by insulin: the role of the forkhead transcription factor FKHRL1 |
| Q44280963 | Elements of the glucocorticoid and retinoic acid response units are involved in cAMP-mediated expression of the PEPCK gene |
| Q93380411 | Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1 |
| Q39385262 | FOXO transcription factors at the interface of metabolism and cancer |
| Q100154284 | FOXO1,FOXO1:PPARGC1A,FOXO3,FOXO4,FOXO6 bind G6PC gene promoter |
| Q54362642 | Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis. |
| Q35860656 | Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice. |
| Q42009070 | Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation |
| Q37431323 | FoxO1 and HNF-4 are involved in regulation of hepatic glucokinase gene expression by resveratrol |
| Q46955933 | FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression |
| Q28258996 | FoxO6 transcriptional activity is regulated by Thr26 and Ser184, independent of nucleo-cytoplasmic shuttling |
| Q33239129 | Functional characterisation of the regulation of CAAT enhancer binding protein alpha by GSK-3 phosphorylation of Threonines 222/226. |
| Q33912958 | Glucose regulation of gene transcription |
| Q35171760 | Identification of candidate transcription factor binding sites in the cattle genome. |
| Q50226931 | Insulin regulation of gluconeogenesis |
| Q28565901 | Insulin regulation of hepatic insulin-like growth factor-binding protein-1 (IGFBP-1) gene expression and mammalian target of rapamycin (mTOR) signalling is impaired by the presence of hydrogen peroxide |
| Q28574617 | Insulin regulation of insulin-like growth factor-binding protein-1 gene expression is dependent on the mammalian target of rapamycin, but independent of ribosomal S6 kinase activity |
| Q43245108 | Insulin resistance and muscle metabolism in chronic kidney disease |
| Q24673179 | Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation |
| Q36884737 | Loss of Interdependent Binding by the FoxO1 and FoxA1/A2 Forkhead Transcription Factors Culminates in Perturbation of Active Chromatin Marks and Binding of Transcriptional Regulators at Insulin-sensitive Genes |
| Q35213690 | Novel concepts in insulin regulation of hepatic gluconeogenesis |
| Q24657473 | Nuclear export-independent inhibition of Foxa2 by insulin |
| Q28344453 | Phorbol ester-induced activation of mitogen-activated protein kinase/extracellular-signal-regulated kinase kinase and extracellular-signal-regulated protein kinase decreases glucose-6-phosphatase gene expression |
| Q50889500 | Physical exercise reduces pyruvate carboxylase (PCB) and contributes to hyperglycemia reduction in obese mice. |
| Q34188064 | Reactive oxygen species suppress cardiac NaV1.5 expression through Foxo1. |
| Q35495099 | Role of transcription factor modifications in the pathogenesis of insulin resistance. |
| Q28087448 | Roles of protein arginine methyltransferases in the control of glucose metabolism |
| Q47868873 | SREBPs suppress IRS-2-mediated insulin signalling in the liver |
| Q43733891 | Selective tonic inhibition of G-6-Pase catalytic subunit, but not G-6-P transporter, gene expression by insulin in vivo |
| Q41517260 | Sequence variation between the mouse and human glucose-6-phosphatase catalytic subunit gene promoters results in differential activation by peroxisome proliferator activated receptor gamma coactivator-1alpha |
| Q24298021 | Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity |
| Q26828607 | Sirtuin 1 and sirtuin 3: physiological modulators of metabolism |
| Q34699239 | Sirtuins as novel players in the pathogenesis of diabetes mellitus |
| Q37677914 | The Fox genes in the liver: from organogenesis to functional integration |
| Q28751831 | The evolution of Fox genes and their role in development and disease |
| Q24670887 | The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression |
| Q24533844 | The glucose-6-phosphatase system |
| Q35684376 | The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation |
| Q40208423 | The promoter for the gene encoding the catalytic subunit of rat glucose-6-phosphatase contains two distinct glucose-responsive regions |
| Q42436400 | The three insulin response sequences in the glucose-6-phosphatase catalytic subunit gene promoter are functionally distinct |
| Q36602626 | Transcriptional regulation by insulin: from the receptor to the gene. |
| Q38077691 | Transcriptional regulators of hepatic gluconeogenesis. |
| Q36104668 | Treatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity |
| Q33701405 | USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy. |
Search more.